Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Net Cash Flow (2021 - 2025)

Medicinova (MNOV) has disclosed Net Cash Flow for 8 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow changed N/A to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$9.6 million for FY2025, 10.1% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$1.1 million at Medicinova, up from -$3.8 million in the prior quarter.
  • The five-year high for Net Cash Flow was $36.8 million in Q1 2023, with the low at -$3.9 million in Q1 2024.
  • Average Net Cash Flow over 5 years is $1.9 million, with a median of -$2.2 million recorded in 2023.
  • The sharpest move saw Net Cash Flow crashed 122.95% in 2022, then surged 1085.72% in 2023.
  • Over 5 years, Net Cash Flow stood at -$3.6 million in 2021, then fell by 3.56% to -$3.7 million in 2022, then soared by 86.62% to -$499038.0 in 2023, then plummeted by 307.16% to -$2.0 million in 2024, then surged by 45.81% to -$1.1 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$1.1 million, -$3.8 million, and -$2.0 million for Q4 2025, Q1 2025, and Q3 2024 respectively.